IHE appoints new Chair of the Board of Directors
The IHE announced today the appointment of Robert Seidel, QC, as Chair of the IHE Board of Directors, for a term of three years.
“The IHE is delighted to welcome Rob Seidel as Board Chair,” said Dr. McCabe, the IHE’s CEO and Executive Director. “Rob Seidel’s extensive experience in board governance and in leading health-related organizations such as Alberta Innovates – Health Solutions has clearly demonstrated his significant expertise and commitment to developing successful partnerships and collaborations which are the foundation of the IHE’s mission. I look forward to working with him in his role as Board Chair as the IHE continues its growth as an independent, internationally recognized, and impactful organization.”
“It is an honour to serve as the Chair of the IHE Board of Directors,” said Rob Seidel. “The IHE occupies a unique space in the health and innovation ecosystem and is well-positioned to make an increasingly important impact in the province and beyond. Building on the legacy of the organization, I look forward to working with the IHE Board and Dr. McCabe to accelerate the implementation of effective and evidence-informed innovations in health delivery.”
Robert Seidel, QC, is the Canada Managing Partner of DLA Piper, a global law firm. He has been Managing Partner since 2007, overseeing significant growth and transition at DLA Piper. He has served on the boards of a number of private and public corporations, and was a member of the Board of the Heritage Foundation for Medical Research and Chair of Alberta Innovates – Health Solutions. He is an engaged community leader with significant experience in both the private and public sectors, including providing guidance on public policy development and analysis.
The IHE would like to extend special thanks to Dr. Jon Meddings, Dean of Medicine of the Cummings School of Medicine, for his service in acting as Interim Board Chair during 2019.
The IHE is an independent, not-for-profit organization that performs excellence in health economics research and health technology assessment. Our core objectives include: supporting decision-making in health policy and practice with evidence from research in health economics and health technology assessment; assessing the medical, economic, social, and ethical implications of both established and new health practices, procedures, and technologies; and facilitating discussions and partnerships among government, academia, industry, and healthcare providers to address important issues in health care. Visit us at www.ihe.ca to learn more.
Senior Policy Director, Institute of Health Economics
Ph: (780) 448-4881